Patent · US Active

Substituted piperidine Degronimers for Target Protein degradation

US12048747B2 · kind B2 · utility

1Cited by

7References

22Claims

0Family size

Assignee

C4 THERAPEUTICS, INC.

Inventors

Andrew J. Phillips · Arlington, US
Christopher G. Nasveschuk · Stoneham, US
James A. Henderson · Cambridge, US
Yanke Liang · Belmont, US
Chi-Li Chen · Newton, US
Martin Duplessis · Somerville, US
Minsheng He · Andover, US
Kiel Lazarski · Cambridge, US

Key dates

Filing date	Dec 14, 2020
Grant date	Jul 30, 2024
Priority date	—
Expiry date	May 27, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides amine-linked C3-glutarimide Degronimers for therapeutic applications as described further herein, and methods of use and compositions thereof as well as methods for their preparation, wherein the C3-glutarimide Degronimers have the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.